Annual report pursuant to Section 13 and 15(d)

5. EQUITY TRANSACTIONS (Details - Options vested)

v3.21.2
5. EQUITY TRANSACTIONS (Details - Options vested) - $ / shares
12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Equity [Abstract]    
Number of shares vested 58,954  
Number of shares expected to vest   785,135
Total number of shares 844,089  
Weighted average exercise price vested $ 20.06  
Weighted average exercise price expected to vest   $ 1.79
Weighted Average Remaining Contractual Term in Years vested 7 years 4 months 6 days  
Weighted Average Remaining Contractual Term in Years expected to vest 9 years 2 months 8 days